LataMed AI is trading 16.11% lower at $0.10, extending its sharp decline from $0.18 on September 21, 2026; no clearly identified catalyst was found for September 23, 2026.

  • Latest verifiable company news remains the September 9 cooperation agreement involving Venezuelan ministries and a planned La Guaira healthcare deployment.
  • Broader markets are modestly lower, but not enough to clearly explain the decline.